These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31430206)

  • 1. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors.
    Chen L; Duan Y; Wei H; Ning H; Bi C; Zhao Y; Qin Y; Li Y
    Expert Opin Investig Drugs; 2019 Oct; 28(10):917-930. PubMed ID: 31430206
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs.
    Wu X; Huang T
    Future Med Chem; 2020 Mar; 12(6):533-561. PubMed ID: 32048880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition.
    Harwood HJ
    Expert Opin Ther Targets; 2005 Apr; 9(2):267-81. PubMed ID: 15934915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of mammalian acetyl-CoA carboxylase.
    Corbett JW; Harwood JH
    Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):162-80. PubMed ID: 18221116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential.
    Luo DX; Tong DJ; Rajput S; Wang C; Liao DF; Cao D; Maser E
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):168-84. PubMed ID: 22339356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH).
    Alkhouri N; Lawitz E; Noureddin M; DeFronzo R; Shulman GI
    Expert Opin Investig Drugs; 2020 Feb; 29(2):135-141. PubMed ID: 31519114
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.
    Marjanovic J; Chalupska D; Patenode C; Coster A; Arnold E; Ye A; Anesi G; Lu Y; Okun I; Tkachenko S; Haselkorn R; Gornicki P
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9093-8. PubMed ID: 20439761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acetyl-CoA carboxylase enzyme: a target for cancer therapy?
    Wang C; Ma J; Zhang N; Yang Q; Jin Y; Wang Y
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):667-76. PubMed ID: 25979092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome.
    Harwood HJ
    Curr Opin Investig Drugs; 2004 Mar; 5(3):283-9. PubMed ID: 15083594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
    Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
    J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.
    Harriman G; Greenwood J; Bhat S; Huang X; Wang R; Paul D; Tong L; Saha AK; Westlin WF; Kapeller R; Harwood HJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1796-805. PubMed ID: 26976583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models.
    Svensson RU; Parker SJ; Eichner LJ; Kolar MJ; Wallace M; Brun SN; Lombardo PS; Van Nostrand JL; Hutchins A; Vera L; Gerken L; Greenwood J; Bhat S; Harriman G; Westlin WF; Harwood HJ; Saghatelian A; Kapeller R; Metallo CM; Shaw RJ
    Nat Med; 2016 Oct; 22(10):1108-1119. PubMed ID: 27643638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the development of acetyl-CoA carboxylase (ACC) inhibitors for the treatment of metabolic disease.
    Bourbeau MP; Bartberger MD
    J Med Chem; 2015 Jan; 58(2):525-36. PubMed ID: 25333641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl-CoA carboxylase-a as a novel target for cancer therapy.
    Wang C; Rajput S; Watabe K; Liao DF; Cao D
    Front Biosci (Schol Ed); 2010 Jan; 2(2):515-26. PubMed ID: 20036965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclohexanedione herbicides are inhibitors of rat heart acetyl-CoA carboxylase.
    Seng TW; Skillman TR; Yang N; Hammond C
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3237-42. PubMed ID: 12951100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.
    Corbett JW
    Expert Opin Ther Pat; 2009 Jul; 19(7):943-56. PubMed ID: 19552511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, function and selective inhibition of bacterial acetyl-coa carboxylase.
    Polyak SW; Abell AD; Wilce MC; Zhang L; Booker GW
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):983-92. PubMed ID: 22183085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting.
    Huard K; Smith AC; Cappon G; Dow RL; Edmonds DJ; El-Kattan A; Esler WP; Fernando DP; Griffith DA; Kalgutkar AS; Ross TT; Bagley SW; Beebe D; Bi YA; Cabral S; Crowley C; Doran SD; Dowling MS; Liras S; Mascitti V; Niosi M; Pfefferkorn JA; Polivkova J; Préville C; Price DA; Shavnya A; Shirai N; Smith AH; Southers JR; Tess DA; Thuma BA; Varma MV; Yang X
    J Med Chem; 2020 Oct; 63(19):10879-10896. PubMed ID: 32809824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Biological Evaluation and Molecular Docking Studies of Piperidinylpiperidines and Spirochromanones Possessing Quinoline Moieties as Acetyl-CoA Carboxylase Inhibitors.
    Huang T; Sun J; Wang Q; Gao J; Liu Y
    Molecules; 2015 Sep; 20(9):16221-34. PubMed ID: 26370948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl CoA carboxylase shares control of fatty acid synthesis with fatty acid synthase in bovine mammary homogenate.
    Wright TC; Cant JP; Brenna JT; McBride BW
    J Dairy Sci; 2006 Jul; 89(7):2552-8. PubMed ID: 16772574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.